Editas Medicine
EDIT
#7842
Rank
โ‚ฌ0.37 B
Marketcap
2,45ย โ‚ฌ
Share price
7.00%
Change (1 day)
12.52%
Change (1 year)

Operating Margin for Editas Medicine (EDIT)

Operating Margin as of November 2026 (TTM): -148.66%

According to Editas Medicine 's latest financial reports and stock price the company's current Operating Margin is -148.66%. At the end of 2021 the company had an Operating Margin of -753.61%.

Operating Margin history for Editas Medicine from 2016 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2021-753.61%489.57%
2020-127.82%-80.38%
2019-651.43%89.21%
2018-344.28%-60.72%
2017-876.49%-45.41%
2016-1,605.53%-64.12%
2015-4,475.14%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Organovo
ONVO
-1,726.38% 1,061.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-129.00%-13.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
39.35%-126.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-17.13%-88.48% Jersey

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.